How inositol phosphate affects aging through nutrient signaling

Unconventional regulation of mTORC1 signaling by inositol phosphate: implications for nutrient-induced premature aging

NIH-funded research University of South Alabama · NIH-11050072

This study is looking at how a natural substance called IP6 might help slow down aging by affecting a specific cell signaling pathway, especially when there's too much sugar around, and it hopes to find ways to improve health and longevity for everyone.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of South Alabama NIH-funded
Lab location1 site (Mobile, United States)
Project IDNIH-11050072 on NIH RePORTER

What this research studies

This research investigates how a small metabolite called inositol hexakisphosphate (IP6) influences the mTORC1 signaling pathway, which is linked to cellular aging. By understanding how excess glucose affects this pathway, the study aims to explore whether targeting IP6 synthesis can help prevent premature aging and promote longevity. The research will involve both laboratory experiments and in vivo assessments to determine the potential benefits of manipulating this metabolic pathway. Patients may benefit from insights gained about dietary influences on aging and health span.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals interested in the effects of nutrition on aging and those who may be experiencing age-related health issues.

Not a fit: Patients who are not concerned about aging or do not have any metabolic conditions related to nutrient processing may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing premature aging and improving health span through dietary modifications.

How similar studies have performed: While the specific approach of targeting IP6 in relation to mTORC1 is novel, previous studies have shown that manipulating mTORC1 signaling can positively impact aging in various animal models.

Where this research is happening

Mobile, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.